Abstract P4-01-03: HDACi (vorinostat) in metastatic breast cancer to restore sensitivity to ER-directed (AI) therapy: A phase II clinical trial with FES imaging correlates

Mapping Intimacies ◽

10.1158/0008-5472.sabcs13-p4-01-03 ◽

2013 ◽

Author(s):

HM Linden ◽

BF Kurland ◽

JM Link ◽

A Novakova ◽

X Chai ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial

Download Full-text

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1013 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1013-1013 ◽

Cited By ~ 20

Author(s):

F. Dalenc ◽

M. Campone ◽

P. Hupperets ◽

R. O'Regan ◽

C. Manlius ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase

Download Full-text

Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2004.n.032 ◽

2004 ◽

Vol 5 (4) ◽

pp. 287-292 ◽

Cited By ~ 13

Author(s):

John R. Mackey ◽

Katia S. Tonkin ◽

Sheryl L. Koski ◽

Andrew G. Scarfe ◽

Michael G.B. Smylie ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Weekly Docetaxel

Download Full-text

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

BMC Cancer ◽

10.1186/s12885-018-4936-y ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 5

Author(s):

Yannan Zhao ◽

Fangfang Lv ◽

She Chen ◽

Zhonghua Wang ◽

Jian Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Caveolin 1

Download Full-text

Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00254257 ◽

1983 ◽

Vol 11 (2) ◽

pp. 108-112 ◽

Cited By ~ 83

Author(s):

Krsto Kolarić ◽

Anton Roth

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Antitumorigenic Activity

Download Full-text

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

Molecular Oncology ◽

10.1002/1878-0261.13091 ◽

2021 ◽

Author(s):

Mariaelena Pierobon ◽

Nicholas J. Robert ◽

Donald W. Northfelt ◽

Mohammad Jahanzeb ◽

Shukmei Wong ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Molecular Profiling ◽

Treatment Selection ◽

Phase Ii Clinical Trial ◽

Efficacious Treatment ◽

Prospective Phase

Download Full-text

Preliminary Results or a Phase II Clinical Trial Utilising Tru-Scint® AD™ in Primary and Metastatic Breast Cancer

Clinical Nuclear Medicine ◽

10.1097/00003072-199410000-00042 ◽

1994 ◽

Vol 19 (10) ◽

pp. 932

Author(s):

A. J.B. McEwan ◽

G. D. MacLean ◽

L. Golberg ◽

K. Golberg ◽

G. R. Boniface ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Preliminary Results

Download Full-text

Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial

BMC Cancer ◽

10.1186/1471-2407-5-21 ◽

2005 ◽

Vol 5 (1) ◽

Cited By ~ 9

Author(s):

Se Hoon Park ◽

Eun Kyung Cho ◽

Soo-Mee Bang ◽

Dong Bok Shin ◽

Jae Hoon Lee ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial

Download Full-text

Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05400-y ◽

2019 ◽

Vol 178 (2) ◽

pp. 367-377

Author(s):

Ji-Yeon Kim ◽

◽

Eunjin Lee ◽

Kyunghee Park ◽

Seock-Ah Im ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Breast Cancer Patients ◽

Biomarker Analysis

Download Full-text

2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70872-8 ◽

2007 ◽

Vol 5 (4) ◽

pp. 217

Author(s):

A. Macias ◽

A. Torres ◽

A. Montenegro ◽

P. Marinello ◽

R. Rodriguez ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Specific Immunotherapy ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Active Specific Immunotherapy ◽

Randomized Phase Ii

Download Full-text

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

Oncology Research and Treatment ◽

10.1159/000027075 ◽

2000 ◽

Vol 23 (1) ◽

pp. 60-62 ◽

Cited By ~ 97

Author(s):

N. Kröger ◽

U.R. Kleeberg ◽

K. Mross ◽

L Edler ◽

D.K. Hossfeld

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Titanocene Dichloride

Download Full-text